OD36 hydrochloride

Modify Date: 2024-01-12 19:01:32

OD36 hydrochloride Structure
OD36 hydrochloride structure
Common Name OD36 hydrochloride
CAS Number 2387510-88-3 Molecular Weight 367.23
Density N/A Boiling Point N/A
Molecular Formula C16H16Cl2N4O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of OD36 hydrochloride


OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM. OD36 hydrochloride is a macrocyclic inhibitor with potent binding to the ALK2 kinase ATP pocket. OD36 hydrochloride shows ALK2-directed activity with KDs of 37 nM[1][2].

 Names

Name OD36 hydrochloride

 OD36 hydrochloride Biological Activity

Description OD36hydrochloride is a RIPK2 inhibitor with an IC50 of 5.3 nM. OD36 hydrochloride is a macrocyclic inhibitor with potent binding to the ALK2 kinase ATP pocket. OD36 hydrochloride shows ALK2-directed activity with KDs of 37 nM[1][2].
Related Catalog
Target

RIPK2:5.3 nM (IC50)

ACVR1:37 nM (Kd)

ACVR1:47 nM (IC50)

ALK2 R206H:22 nM (IC50)

In Vitro OD36 also inhibits ALK2 and ALK2 R206H with IC50s of 47 and 22 nM, respevtively[1]. OD36 shows activity against ALK1 with a KD of 90 nM[2]. OD36 potently antagonize mutant ALK2 signaling and osteogenic differentiation[2]. OD36 (0.1-1 μM; 24 h) efficiently inhibits BMP-6 (50 ng/mL)-induced p-Smad1/5 in KS483 cells[2]. Preincubation of fibrodysplasia ossificans progressiva (FOP) endothelial colony-forming cells (ECFCs) with OD36 (0.5 μM) completely prevents the activation of Smad1/5 and gene targets ID-1 and ID-3 in response to activin A[2]. Western Blot Analysis[2] Cell Line: KS483 cells Concentration: 0.1, 0.2, and 1 μM Incubation Time: 24 h Result: Inhibited BMP-6 induced p-Smad1/5.
In Vivo OD36 (6.25 mg/kg; i.p.; once) alleviates inflammation in an acute peritonitis mice model[3]. Animal Model: C57BL/6 mice, muramyl dipeptide (MDP)-induced model of peritonitis[3] Dosage: 6.25 mg/kg Administration: Intraperitoneal injection, 30 min prior to MDP Result: Inhibited the recruitment of inflammatory cells to the peritoneum, specifically that of neutrophils, and, to a lesser extent, lymphocytes. Decreased RIPK2-specific genes as well as inflammatory cytokine and chemokine gene expression.
References

[1]. Justine T Tigno-Aranjuez, et al. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem. 2014 Oct 24;289(43):29651-64.

[2]. Gonzalo Sánchez-Duffhues, et al. Development of Macrocycle Kinase Inhibitors for ALK2 Using Fibrodysplasia Ossificans Progressiva-Derived Endothelial Cells. JBMR Plus. 2019 Oct 7;3(11):e10230.

[3]. Tigno-Aranjuez JT, et al. In vivo inhibition of RIPK2 kinase alleviates inflammatory disease. J Biol Chem. 2014 Oct 24;289(43):29651-64.

 Chemical & Physical Properties

Molecular Formula C16H16Cl2N4O2
Molecular Weight 367.23